Journal of Peking University(Health Sciences) ›› 2019, Vol. 51 ›› Issue (4): 716-722. doi: 10.19723/j.issn.1671-167X.2019.04.021
Previous Articles Next Articles
Hong-lin ZHU,Qian DU,Wei-lin CHEN,Xiao-xia ZUO,Quan-zhen LI,Si-jia LIU()
CLC Number:
[1] | Denton CP, Khanna D . Systemic sclerosis[J]. Lancet, 2017,390(10103):1685-1699. |
[2] | Allanore Y, Simms R, Distler O , et al. Systemic sclerosis[J]. Nat Rev Dis Primers, 2015: 15002.( 2015-04-23)[2018-12-01]. . |
[3] | LeRoy EC, Black C, Fleischmajer R , et al. Scleroderma (syste-mic sclerosis): classification, subsets and pathogenesis[J]. J Rheumatol, 1988,15(2):202-205. |
[4] | Bhattacharyya S, Wei J, Varga J . Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities[J]. Nat Rev Rheumatol, 2011,8(1):42-54. |
[5] | Raja J, Denton CP . Cytokines in the immunopathology of systemic sclerosis[J]. Semin Immunopathol, 2015,37(5):543-557. |
[6] | Dantas AT, Almeida AR, Sampaio M , et al. Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations[J]. Immunol Lett, 2018,198:12-16. |
[7] | Zhu H, Zhu C, Mi W , et al. Integration of genome-wide DNA methylation and transcription uncovered aberrant methylation-regulated genes and pathways in the peripheral blood mononuclear cells of systemic sclerosis[J]. Int J Rheumatol, 2018:7342472.(2018-09-02)[2018-12-11]. . |
[8] | Masi AT . Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee[J]. Arthritis Rheum, 1980,23(5):581-590. |
[9] | Burska A, Boissinot M , Ponchel F. Cytokines as biomarkers in rheumatoid arthritis[J]. Mediators Inflamm, 2014: 545493.( 2014-03-09)[2018-12-22].. |
[10] | Needleman BW, Wigley FM, Stair RW . Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma[J]. Arthritis Rheum, 1992,35(1):67-72. |
[11] | Hasegawa M, Fujimoto M, Kikuchi K , et al. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis[J]. J Rheumatol, 1997,24(2):328-332. |
[12] | Hasegawa M, Fujimoto M, Matsushita T , et al. Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis[J]. Clin Rheumatol, 2011,30(2):231-237. |
[13] | Wuttge DM, Wildt M, Geborek P , et al. Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease[J]. Arthritis Res Ther, 2007,9(5):R85. |
[14] | Takada T, Ohashi K, Hayashi M , et al. Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody[J]. Respir Med, 2018,141:7-13. |
[15] | Antonelli A, Ferri C, Fallahi P , et al. CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis: a longitudinal study[J]. Rheumatology (Oxford), 2008,47(1):45-49. |
[16] | Goser S, Ottl R, Brodner A , et al. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy[J]. Circulation, 2005,112(22):3400-3407. |
[17] | Feinberg AP . The key role of epigenetics in human disease prevention and mitigation[J]. N Engl J Med, 2018,378(14):1323-1334. |
[18] | McInnes IB, Buckley CD, Isaacs JD . Cytokines in rheumatoid arthritis-shaping the immunological landscape[J]. Nat Rev Rheumatol, 2016,12(1):63-68. |
[19] | van der Heijde D, Cheng-Chung Wei J, Dougados M , et al. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial[J]. Lancet, 2018,392(10163):2441-2451. |
[20] | Chen Z, Bozec A, Ramming A , et al. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis[J]. Nat Rev Rheumatol, 2019,15(1):9-17. |
[1] | Jiajun LIU, Guokang LIU, Yuhu ZHU. Immune-related severe pneumonia: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 932-937. |
[2] | Wen-gen LI,Xiao-dong GU,Rui-qiang WENG,Su-dong LIU,Chao CHEN. Expression and clinical significance of plasma exosomal miR-34-5p and miR-142-3p in systemic sclerosis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1022-1027. |
[3] | Zhuo-hua LIN,Ru-yi CAI,Yang SUN,Rong MU,Li-gang CUI. Methodology and clinical use of superb microvascular imaging in assessing micro-circulation changes of fingertips in systemic sclerosis [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 636-640. |
[4] | YANG Duo,ZHOU Xin-na,WANG Shuo,WANG Xiao-li,YUAN Yan-hua,YANG Hua-bin,GENG Hui-zhen,PENG Bing,LI Zi-bo,LI Bin,REN Jun. Assessment of lymphocytic function in vitro stimulated by specific tumor polypeptide combined with dendritic cells [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1094-1098. |
[5] | MA Xiang-bo,ZHANG Xue-wu,JIA Ru-lin,GAO Ying,LIU Hong-jiang,LIU Yu-fang,LI Ying-ni. Application of lymphocytes test in peripheral blood of patients with systemic sclerosis during the treatment [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 721-727. |
[6] | Jing ZHAO,Feng SUN,Yun LI,Xiao-zhen ZHAO,Dan XU,Ying-ni LI,Yu-hui LI,Xiao-lin SUN. Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1009-1013. |
[7] | Jia-xing LIU,Gui-ping HU,Lin ZHAO,Yong-ming ZHANG,Li WANG,Guang JIA,Rui-xiang LIU,Hui-min FENG,Hua-dong XU. Early effects of low-level long-term occupational chromate exposure on workers’ health [J]. Journal of Peking University(Health Sciences), 2019, 51(2): 307-314. |
[8] | DOU Jing-li,BAI Li,PANG Chun-yan,ZHANG Wen-lan,ZHANG Wei,WANG Yong-fu. Therapeutic effect of adipose tissue-derived stem cells on bleomycin-induced mice of scleroderma [J]. Journal of Peking University(Health Sciences), 2016, 48(6): 970-976. |
[9] | AN Le-mei, LI Juan, JI Lan-lan, LI Guang-tao, ZHANG Zhuo-li. Detection of peripheral follicular helper T cells in rheumatoid arthritis [J]. Journal of Peking University(Health Sciences), 2016, 48(6): 951-957. |
[10] | WANG Zhi-hua, ZHANG Wei, ZHANG Yan-qing, PANG Chun-yan,WANG Yong-fu. Effect of CD40 siRNA on inflammatory response of MRL/Lpr mice [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 771-776. |
[11] | LI Hao, ZHANG You-Yi. Roles of proinflammatory cytokines in cardiac remodeling induced by sympathetic nervous system /catecholamine [J]. Journal of Peking University(Health Sciences), 2014, 46(6): 1001-1004. |
|